Proposed Calibration of Apheresis Equipment
Main Article Content
Keywords
Qualification of Incorporation, Biomedical Equipment, Calibration of Apheresis Machines
Abstract
It is under development in health establishment, a quality control through the calibration of biomedical equipment, in a systematic and comprehensive way of the wide range of available hospital technology. Thus, this work aims to propose and demonstrate a method of qualification of the apheresis equipment through of the equipment calibration, before to release it for the first time use. As results are shown the values obtained in a calibration of an apheresis equipment, relating to the MNC protocol (removal of mononuclear cells), the pressure of access and return pressure.
Downloads
Download data is not yet available.
Abstract 1051 | PDF Downloads 576
References
1. Quesenberry PJ, Colvin GA, Beutler E, et al. Williams Hematology, North America 2001;6:153–74.
2. Zerlotti HWG, Noronha JFA. Identification of hemato-poietic stem cells: conventional flow cytometry versus automated hematology counter view. Braz Hematol Hemother 2003;169–72.
3. Grimm DJ. Apheresis system with anticoagulant flow. US: Baxter; 2005.
4. Marikar A, Tatsui NH. Therapeutic Aféreses. Cap 2001;21:257–71.
5. Hlavinka DJ, Felt TJ. Centrifugal separation method for separating fluid components US, Google Patents, Gambro; 1999.
6. Gambro. Model Cobe Spectra. Introduction to User Manual. Rev. E; 2001.
7. Schmaldienst S, Goldammer A, Derfler K, et al. Location of the extracorporeal circuit anticoagulation with heparin neutralization with protamine by the company and during immune ergatterte. Division of Hematology and Blood Coagulation, University of Vienna, 2000;Sep-tember 36:490–97.
8. Octavian CJ. Serological evaluation for infectious diseases transmitted through blood transfusion in blood recipients, General Hospital of Palmas, Brazil dissertation; 2015.
9. ANVISA. The National Health Surveillance Agency of the Brazilian. Resolution RDC 57 Collegiate Board of Directors of the Brazilian, No. 57. 2010. Available at https://portal.anvisa.gov.br.
2. Zerlotti HWG, Noronha JFA. Identification of hemato-poietic stem cells: conventional flow cytometry versus automated hematology counter view. Braz Hematol Hemother 2003;169–72.
3. Grimm DJ. Apheresis system with anticoagulant flow. US: Baxter; 2005.
4. Marikar A, Tatsui NH. Therapeutic Aféreses. Cap 2001;21:257–71.
5. Hlavinka DJ, Felt TJ. Centrifugal separation method for separating fluid components US, Google Patents, Gambro; 1999.
6. Gambro. Model Cobe Spectra. Introduction to User Manual. Rev. E; 2001.
7. Schmaldienst S, Goldammer A, Derfler K, et al. Location of the extracorporeal circuit anticoagulation with heparin neutralization with protamine by the company and during immune ergatterte. Division of Hematology and Blood Coagulation, University of Vienna, 2000;Sep-tember 36:490–97.
8. Octavian CJ. Serological evaluation for infectious diseases transmitted through blood transfusion in blood recipients, General Hospital of Palmas, Brazil dissertation; 2015.
9. ANVISA. The National Health Surveillance Agency of the Brazilian. Resolution RDC 57 Collegiate Board of Directors of the Brazilian, No. 57. 2010. Available at https://portal.anvisa.gov.br.
